Published in Pharma Investments, Ventures and Law Weekly, October 1st, 2006
Researchers in the United States report, "The goal of this study was to compare the predictive ability of S100B, N-methyl-D-aspartate (NMDA) receptor antibodies (NR2Ab) and C-reactive protein (CRP) for neurological deficits after cardiac surgery with cardiopulmonary bypass (CPB)."
"We investigated 557 high-risk adult patients who underwent coronary artery or valve replacement surgery using CPB as a substudy...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures and Law Weekly